Examkin

Question

Difficulty: MediumMonitoring and Treatment Evaluation

A 24-year-old individual presents to the emergency department with severe chest tightness, expiratory wheezing, and significant accessory muscle use. The patient has a history of moderate persistent asthma but recently exhausted their supply of maintenance inhalers. Oxygen saturation is 88% on ambient air. The clinical team prepares to manage this severe acute exacerbation.

Arrange the following therapeutic and monitoring steps in the most appropriate chronological sequence for managing this patient's condition.

  1. 1Deliver nebulized albuterol and ipratropium alongside supplemental oxygen.
  2. 2Administer systemic corticosteroids to address the underlying inflammatory cascade.
  3. 3Evaluate objective treatment response by measuring the peak expiratory flow rate.
  4. 4Provide intravenous magnesium sulfate for persistent airflow obstruction.
  5. 5Initiate non-invasive positive pressure ventilation for impending respiratory fatigue.

Answer

The correct sequence begins with immediate bronchodilation and oxygen, followed by systemic corticosteroids, then objective reassessment of airflow, escalating to intravenous magnesium for refractory symptoms, and finally initiating mechanical ventilatory support if respiratory fatigue occurs.
The established protocol for severe asthma exacerbations dictates a step-up approach, heavily relying on continuous monitoring and treatment evaluation. Hypoxia and severe bronchospasm are the most immediate threats and must be addressed first with oxygen, albuterol, and ipratropium. Systemic corticosteroids should be administered concurrently or immediately following to begin combatting the severe inflammatory response. The critical 'monitoring and evaluation' step occurs next: assessing the patient's clinical work of breathing and peak expiratory flow (PEF) after initial therapy. If the patient demonstrates a poor response (e.g., PEF remains below 40% of predicted), therapy is escalated to intravenous magnesium sulfate. If the patient subsequently develops hypercapnia or exhaustion despite maximal pharmacological therapy, mechanical support via continuous positive airway pressure (CPAP) or endotracheal intubation is required.

Step-by-Step Solution

1
Identify the immediate life-threatening issues (hypoxia and severe bronchospasm).
Prioritization of oxygenation and short-acting bronchodilators as the first intervention.
Without rapidly reversing the acute airway obstruction and correcting hypoxemia, the patient risks sudden respiratory arrest.
2
Address the underlying pathophysiology of the exacerbation.
Administration of systemic corticosteroids.
Asthma exacerbations are fundamentally driven by severe inflammation. Steroids take hours to reach maximal effect, so they must be given early in the treatment sequence.
3
Determine the efficacy of the initial tier of therapy.
Measurement of peak expiratory flow rate (PEF) and clinical reassessment.
Treatment evaluation is essential before committing to advanced adjunctive therapies. Objective measures and clinical signs dictate the next level of care.
4
Escalate medical therapy for a poor initial response.
Administration of intravenous magnesium sulfate.
Patients who remain in severe distress after initial treatment require adjunctive bronchodilation to prevent the need for intubation.
5
Manage impending ventilatory failure.
Application of non-invasive positive pressure ventilation (or intubation).
When all pharmacological options fail and the patient tires from the excessive work of breathing, mechanical support is required to maintain gas exchange.

Key Concept

The stepwise approach to severe acute asthma involves immediate rescue bronchodilation, early administration of anti-inflammatories, objective monitoring of treatment response, and subsequent escalation to adjuncts or mechanical support only if primary therapies fail.
Estimated Time:1m 30s
Rate this question

Topics

Monitoring and Treatment Evaluation

More questions from this topic